...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Add one to the list
Reply New Message
Back To Forum List View
Add one to the list
4
jonzobot
Sep 12, 2023 11:35AM

I don't understand how Zenith epigenetics is not listed as a sponsor or collaborator in this new trial..  The Fact that Zenith owns the IP to ZEN3694 you would think they would want some acknowledgement and guidance  in the trial?

Can anyone give a logical reason for the Zen not to be involved? i get it they are not paying for the trial but still???

2 Recommendations
Re: Add one to the list
4
narmac
Sep 13, 2023 07:02AM
Icon president Re: Add one to the list
4
Nextblockbuster
Sep 13, 2023 10:17AM
Re: Add one to the list
3
KOO-KOO2
Sep 13, 2023 11:47AM
Re: Add one to the list
3
jonzobot
Sep 13, 2023 11:47AM
Re: Add one to the list
1
fuzzyjr
Sep 13, 2023 01:27PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply